1 |
Wilson JF. Liver cancer on the rise. Ann Intern Med. 2005,142(12 Pt 1): 1029-1032.
|
2 |
Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis, 2010, 30 (1): 3-16.
|
3 |
Bandyopadhyay A, Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets, 2009, 10(7): 645-652.
|
4 |
Patsenker E, Popov Y, Stickel F, et al. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology, 2008, 135(2): 660-670.
|
5 |
Marsh D, Dickinson S, Neill GW, et al. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res, 2008,68(9): 3295-3303.
|
6 |
Zhang ZY, Xu KS, Wang JS, et al. Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma. Clin Oncol (R Coll Radiol), 2008,20(1): 61-66.
|
7 |
刘松,刘恩字,牛卫博, 等. 整合素αvβ6在胃癌AGS细胞增殖和凋亡中的作用. 中国现代普通外科进展, 2010, 13(2): 102-104.
|
8 |
Patsenker E, Wilkens L, Banz V, et al. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. J Hepatol, 2010, 52(3): 362-369.
|
9 |
Yang GY, Xu KS, Pan ZQ, et al. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci, 2008, 99(5): 879-887.
|
10 |
Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest, 2005, 115(2): 339-347.
|
11 |
彭程,张琦,牛卫博, 等. 整合素αvβ6与钙黏蛋白Fat1在结肠癌中的表达差异性及其意义. 中国现代普通外科进展, 2010, 3(8): 589-593.
|
12 |
Niu W, Liu X, Zhang Z, et al. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells. Anticancer Res, 2010, 30(1): 135-142.
|
13 |
Popov Y, Patsenker E, Stickel F, et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J Hepatol, 2008, 48(3): 453-464.
|
14 |
Patsenker E, Wilkens L, Banz V, et al. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma. J Hepatol, 2010, 52(3): 362-369.
|
15 |
Zhang S, Jiang T, Feng L, et al. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha. J Mol Med (Berl), 2012, 90(9): 1069-1077.
|
16 |
Zhu Q, Wang Z, Hu Y, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep, 2012, 27(5): 1660-1668.
|
17 |
Chen RX, Xia YH, Xue TC, et al. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression. J Exp Clin Cancer Res, 2010, 29(2): 172.
|
18 |
Parija T, Das BR. Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by d-limonene. Mol Biol Rep, 2003, 30(1): 41-46.
|